TipRanks
Go Ultimate55% OFF

PolyPeptide Group AG (PPGN) Stock Forecast & Price Target

See the Price Targets and Ratings of:All AnalystsTop AnalystsPremium

PPGN Analyst Ratings

Hold
3Ratings
0Buy3Hold0Sell
Based on 3 analysts giving stock ratings to PolyPeptide Group AG in the past 3 months

PPGN Stock 12 Month Forecast

CHF 44.10▲(5.01% Upside)
Based on 3 Wall Street analysts offering 12 month price targets for PolyPeptide Group AG in the last 3 months. The average price target is CHF 44.10 with a high forecast of CHF 44.31 and a low forecast of CHF 44.00. The average price target represents a 5.01% change from the last price of CHF 42.00.
Highest Price TargetCHF 44.31Average Price TargetCHF 44.10Lowest Price TargetCHF 44.00

Detailed List of Analyst Forecasts​

Analyst Type
Ranks
Analyst Rating
Upside/ Downside
Action
Analyst forecasts for CH:PPGN
Analyst ProfileExpert FirmPrice TargetPositionUpside / DownsideActionDateFollowArticle
UBSCHF 45→CHF 44hold4.76%UpsideDowngraded10/06/26
BarclaysCHF 44.31hold5.50%UpsideReiterated09/08/26
Berenberg BankCHF 38→CHF 44hold4.76%UpsideDowngraded08/18/26
RBC CapitalCHF 44hold4.76%UpsideDowngraded07/07/26
Stocks with the Highest Top Analyst Consensus in the General Sector
STDNStandard Nuclear
SKHYSK Hynix
ITGITG Inc. Class A
LIMENeutron Holdings, Inc.
EROCERock

Find stocks in the General sector that are highly recommended by Top Performing Analysts.

PPGN Analyst Recommendation Trends

02468Oct 25Nov 25Dec 25Jan 26Feb 26Mar 26Apr 26May 26Jun 26Jul 26Aug 26Sep 26
Monthly rating counts for PPGN
RatingMay 26Jun 26Jul 26Aug 26Sep 26
Strong Buy00000
Buy74300
Hold01344
Sell00000
Strong Sell00000
total75644

In the current month, PPGN has received 0 Buy Ratings, 4 Hold Ratings, and 0 Sell Ratings. PPGN average Analyst price target in the past 3 months is 44.10.

PPGN Financial Forecast

CHF -2CHF -1.25CHF -0.5CHF 0.25CHF 1Q2 2025Q2 2026Q4 2026
HighCHF 0.36
ConsensusCHF 0.36
LowCHF 0.36

PPGN Earnings Forecast

Next quarter’s earnings estimate for PPGN is CHF 0.36 with a range of CHF 0.36 to CHF 0.36. The previous quarter’s EPS was CHF 0.26. PPGN beat its EPS estimate ― of the time in the past 12 months, while its overall industry beat the EPS estimate 50.49% of the time in the same period. In the last calendar year PPGN has Performed in-line its overall industry.

CHF 157.3MCHF 177.2MCHF 197.1MCHF 216.9MCHF 236.8MQ2 2025Q2 2026Q4 2026
HighCHF 237M
ConsensusCHF 237M
LowCHF 237M

PPGN Sales Forecast

Next quarter’s sales forecast for PPGN is CHF 236.76M with a range of CHF 236.76M to CHF 236.76M. The previous quarter’s sales results were CHF 217.20M. PPGN beat its sales estimates ― of the time in past 12 months, while its overall industry beat sales estimates 63.25% of the time in the same period. In the last calendar year PPGN has Performed in-line its overall industry.

PPGN Stock Forecast FAQ

What is CH:PPGN’s average 12-month price target, according to analysts?
Based on analyst ratings, PolyPeptide Group AG’s 12-month average price target is CHF44.10.
What is CH:PPGN’s upside potential, based on the analysts’ average price target?
PolyPeptide Group AG has 5.01% upside potential, based on the analysts’ average price target.
Can I see which stocks the top-ranking analysts are rating?
Yes, go to the Analysts’ Top Stocks tool to see stocks with a Strong Buy or Strong Sell analyst rating consensus, according to the top performers.
How can I follow the stock ratings of top Wall Street analysts?
Head over to our Expert Center to see a list of the top 100 Wall Street analysts and follow the analysts of your choice. Visit their profiles for more details about their stock ratings and see how they perform on a stock-by-stock basis.
Is PolyPeptide Group AG a Buy, Sell or Hold?
PolyPeptide Group AG has a consensus rating of Hold, which is based on 0 buy ratings, 3 hold ratings and 0 sell ratings.
What is PolyPeptide Group AG’s share price target?
The average share price target for PolyPeptide Group AG is CHF44.10. This is based on 3 Wall Street analysts’ 12-month price targets, issued in the past 3 months. The highest analyst share price target is CHF44.31, and the lowest forecast is CHF44.00. The average share price target represents a 5.01% increase from the current price of CHF42.
What do analysts say about PolyPeptide Group AG?
PolyPeptide Group AG’s analyst rating consensus is a Hold. This is based on the ratings of 3 Wall Street analysts.
How can I buy shares of PolyPeptide Group AG?
To buy shares of CH:PPGN, you can open a brokerage account. See exclusive account opening deals on our Best Online Brokers page.